Covered recipient · General Payments record
SUSAN LOUISE PEDEN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$2,483.36
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.67 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $84.61 | 3 |
| GENZYME CORPORATION | $58.90 | 2 |
| E.R. Squibb & Sons, L.L.C. | $47.38 | 3 |
| Janssen Biotech, Inc. | $23.68 | 1 |
| Arcutis Biotherapeutics, Inc. | $22.92 | 1 |
| Dermavant Sciences, Inc. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | $22.92 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121123987 | CMS |
| Dermavant Sciences, Inc. | $14.18 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127967805 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.84 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101304759 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.77 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101304789 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.77 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101304785 | CMS |
| GENZYME CORPORATION | $31.43 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139948405 | CMS |
| GENZYME CORPORATION | $27.47 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139948427 | CMS |
| Janssen Biotech, Inc. | $23.68 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078562142 | CMS |
| Lilly USA, LLC | $19.50 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869195 | CMS |
| Lilly USA, LLC | $32.11 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917593 | CMS |
| Lilly USA, LLC | $33.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917591 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.